Jenna Lambeth, MD
Pain Medicine · Belmont, NCNPI 1376860924
Payments from drug & device makers
What this record shows
16 manufacturers reported payments, led by Abbott at 59.3% of the total. Reporting peaked in 2023 at $5,782 and has fallen 75.6% since, to $1,411 in 2025.
Across 145 payments — averaging $72.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$6K
- Relievant Medsystems, Inc.$1K
- SPR Therapeutics, Inc$945
- Boston Scientific$630
- Medtronic$584
- Nevro Corp.$296
- plus $747 from 10 others
What the payments were for
- Travel & lodging$5,03248%
- Food & beverage$5,49452%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 55 | $6,242 |
| Relievant Medsystems, Inc. | 9 | $1,081 |
| SPR Therapeutics, Inc | 22 | $945 |
| Boston Scientific | 21 | $630 |
| Medtronic(2 entities) | 13 | $584 |
| Nevro Corp. | 6 | $296 |
| Saluda Medical Americas, Inc. | 3 | $231 |
| Globus Medical | 4 | $197 |
| Forte Bio-pharma LLC | 3 | $78 |
| AbbVie | 3 | $72 |
| Vertos Medical, Inc. | 1 | $54 |
| Si-bone, Inc. | 1 | $42 |
| Curonix LLC | 1 | $19 |
| Nalu Medical, Inc. | 1 | $18 |
| Spinal Simplicity, LLC | 1 | $18 |
| Novo Nordisk | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$4,680
- Intracept$3,200
- Proclaim IPG$238
- Senza$145
- SPRINT PNS System$118
- SYNCHROMED$118
- ETERNA$109
- INTELLIS ADAPTIVESTIM$108
- Evoke$104
How this compares
$10,526 in reported general payments places this provider in the 75th percentile of 182 pain medicine providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 39 | $1,582 |
| Gabapentin | 123 | $1,104 |
| Pregabalin | 35 | $772 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 29 | $681 |
| Methocarbamol | 46 | $449 |
| Duloxetine Hcl | 13 | $214 |
| Tizanidine Hcl | 22 | $142 |
| Celecoxib | 17 | $93 |
| Tramadol Hcl | 14 | $83 |
| Methylprednisolone | 13 | $50 |
| Meloxicam | 19 | $30 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Belmont
- James NorthWinston Salem$721K
- Leonardo KapuralWinston Salem$523K
- Christopher GilmoreWinston Salem$457K
- Richard RauckWinston Salem$431K
- Courtney AumanJacksonville$186K
- Jacob WangCharlotte$162K
- Aashish KumarCharlotte$160K
- Javid BakshAsheville$116K
- David ZubLeland$97K
- James DeeringCharlotte$93K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.